Stock listing
NSE:ORTINGLOBE Ortin Global Ltd Share Price
Home listing (NSE) of Ortin Global Ltd
Follow Ortin Global Ltd into a list and get an email when it puts out news.
Share price · NSE:ORTINGLOBE
₹12.37 INR -0.63 (-4.8%)
Close on Nov 20, 2026
- Day range
- ₹12.35 – ₹12.87 INRNov 20, 2026
- Volume
- 8,032 sharesNov 20, 2026
- Market cap
- ₹100.6M INRAt the close on Nov 20, 2026 · price × 8.13M shares outstanding
- 52-week range
- ₹11.33 – ₹21.30 INRLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- ₹147,883 INRMedian day 6,844 shares · 2 days with no trades · last 3 months, Aug 20, 2026 – Nov 20, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NSE:ORTINGLOBE · Home | ₹12.37 INR | -0.63 (-4.8%) | 8,032 | ₹12.40 | ₹12.87 | ₹12.35 | ₹13.00 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NSE:ORTINGLOBE · INR, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| ₹12.37 | -0.63 | -4.8% | ₹12.40 | ₹12.87 | ₹12.35 | 8,032 | |
| ₹13.00 | -0.28 | -2.1% | ₹13.60 | ₹13.60 | ₹12.63 | 2,014 | |
| ₹13.28 | +0.78 | +6.2% | ₹12.88 | ₹13.30 | ₹12.55 | 14,230 | |
| ₹12.50 | -0.43 | -3.3% | ₹12.90 | ₹13.73 | ₹12.50 | 15,055 | |
| ₹12.93 | -0.62 | -4.6% | ₹13.55 | ₹13.97 | ₹12.75 | 10,103 | |
| ₹13.55 | -0.42 | -3.0% | ₹13.98 | ₹14.39 | ₹13.50 | 9,567 | |
| ₹13.97 | -0.01 | -0.1% | ₹13.00 | ₹14.45 | ₹13.00 | 1,457 | |
| ₹13.98 | +0.96 | +7.4% | ₹14.04 | ₹14.79 | ₹13.25 | 3,599 | |
| ₹13.02 | -0.88 | -6.3% | ₹13.92 | ₹13.92 | ₹13.00 | 13,955 | |
| ₹13.90 | +0.10 | +0.7% | ₹13.80 | ₹13.98 | ₹13.00 | 1,075 | |
| ₹13.80 | +0.76 | +5.8% | ₹13.97 | ₹13.97 | ₹13.12 | 4,227 | |
| ₹13.04 | -0.57 | -4.2% | ₹13.30 | ₹13.88 | ₹13.00 | 1,281 | |
| ₹13.61 | +0.26 | +1.9% | ₹13.35 | ₹13.88 | ₹12.60 | 1,617 | |
| ₹13.35 | +0.22 | +1.7% | ₹13.50 | ₹13.98 | ₹12.40 | 2,096 | |
| ₹13.13 | +0.72 | +5.8% | ₹12.41 | ₹13.50 | ₹12.00 | 6,702 | |
| ₹12.41 | -0.34 | -2.7% | ₹12.50 | ₹13.39 | ₹12.26 | 2,374 | |
| ₹12.75 | -0.41 | -3.1% | ₹12.51 | ₹13.84 | ₹12.51 | 2,202 | |
| ₹13.16 | +0.32 | +2.5% | ₹14.00 | ₹14.00 | ₹12.12 | 3,503 | |
| ₹12.84 | -0.48 | -3.6% | ₹13.60 | ₹13.60 | ₹12.10 | 14,545 | |
| ₹13.32 | -0.21 | -1.6% | ₹13.56 | ₹14.63 | ₹13.11 | 4,658 | |
| ₹13.53 | -0.89 | -6.2% | ₹14.56 | ₹14.56 | ₹13.11 | 4,887 | |
| ₹14.42 | +0.08 | +0.6% | ₹14.35 | ₹14.45 | ₹14.35 | 3,320 | |
| ₹14.34 | +0.04 | +0.3% | ₹14.30 | ₹15.23 | ₹14.00 | 9,474 | |
| ₹14.30 | -0.15 | -1.0% | ₹14.38 | ₹15.29 | ₹14.00 | 7,612 | |
| ₹14.45 | -0.83 | -5.4% | ₹15.15 | ₹15.29 | ₹14.22 | 17,730 | |
| ₹15.28 | +0.35 | +2.3% | ₹15.00 | ₹15.29 | ₹14.20 | 11,679 | |
| ₹14.93 | +1.10 | +8.0% | ₹14.48 | ₹15.20 | ₹14.10 | 9,324 | |
| ₹13.83 | -0.55 | -3.8% | ₹14.67 | ₹14.67 | ₹13.50 | 11,036 | |
| ₹14.38 | -0.52 | -3.5% | ₹14.60 | ₹14.80 | ₹14.00 | 13,680 | |
| ₹14.90 | +0.51 | +3.5% | ₹14.68 | ₹15.10 | ₹14.10 | 6,452 | |
| ₹14.39 | +0.57 | +4.1% | ₹13.82 | ₹14.51 | ₹13.80 | 9,315 | |
| ₹13.82 | -0.70 | -4.8% | ₹14.36 | ₹14.84 | ₹13.82 | 25,484 | |
| ₹14.52 | 0.00 | 0.0% | ₹14.52 | ₹14.52 | ₹14.52 | 0 | |
| ₹14.52 | +0.20 | +1.4% | ₹14.32 | ₹15.03 | ₹14.11 | 1,329 | |
| ₹14.32 | -0.40 | -2.7% | ₹15.20 | ₹15.20 | ₹14.25 | 7,318 | |
| ₹14.72 | +0.07 | +0.5% | ₹15.00 | ₹15.21 | ₹13.92 | 24,048 | |
| ₹14.65 | -0.58 | -3.8% | ₹14.66 | ₹15.20 | ₹14.65 | 3,622 | |
| ₹15.23 | +0.48 | +3.3% | ₹14.50 | ₹15.24 | ₹14.50 | 2,977 | |
| ₹14.75 | -0.35 | -2.3% | ₹15.29 | ₹15.30 | ₹14.63 | 6,081 | |
| ₹15.10 | +0.36 | +2.4% | ₹14.70 | ₹15.19 | ₹14.70 | 7,046 | |
| ₹14.74 | -0.62 | -4.0% | ₹15.35 | ₹15.64 | ₹14.60 | 52,473 | |
| ₹15.36 | -0.47 | -3.0% | ₹15.21 | ₹16.40 | ₹15.21 | 11,750 | |
| ₹15.83 | -0.62 | -3.8% | ₹15.70 | ₹16.68 | ₹15.67 | 8,090 | |
| ₹16.45 | -0.80 | -4.6% | ₹17.33 | ₹17.33 | ₹16.40 | 4,055 | |
| ₹17.25 | +0.63 | +3.8% | ₹16.63 | ₹17.38 | ₹16.01 | 11,645 | |
| ₹16.62 | -0.47 | -2.8% | ₹17.50 | ₹17.58 | ₹16.62 | 17,178 | |
| ₹17.09 | 0.00 | 0.0% | ₹17.09 | ₹17.09 | ₹17.09 | 0 | |
| ₹17.09 | +0.79 | +4.8% | ₹16.70 | ₹17.11 | ₹15.81 | 30,391 | |
| ₹16.30 | +0.77 | +5.0% | ₹15.50 | ₹16.30 | ₹15.22 | 31,447 | |
| ₹15.53 | -0.40 | -2.5% | ₹15.54 | ₹16.29 | ₹15.53 | 2,934 | |
| ₹15.93 | +0.49 | +3.2% | ₹16.20 | ₹16.20 | ₹15.32 | 57,526 | |
| ₹15.44 | -0.23 | -1.5% | ₹15.82 | ₹15.89 | ₹15.26 | 5,143 | |
| ₹15.67 | +0.65 | +4.3% | ₹15.70 | ₹15.77 | ₹15.20 | 9,743 | |
| ₹15.02 | -0.41 | -2.7% | ₹15.05 | ₹15.77 | ₹15.00 | 2,598 | |
| ₹15.43 | -0.43 | -2.7% | ₹15.36 | ₹15.86 | ₹15.36 | 2,952 | |
| ₹15.86 | +0.56 | +3.7% | ₹15.34 | ₹16.06 | ₹14.80 | 36,130 | |
| ₹15.30 | +0.37 | +2.5% | ₹15.00 | ₹15.30 | ₹14.65 | 1,215 | |
| ₹14.93 | -0.17 | -1.1% | ₹15.10 | ₹15.38 | ₹14.86 | 6,400 | |
| ₹15.10 | -0.25 | -1.6% | ₹14.72 | ₹15.74 | ₹14.72 | 4,209 | |
| ₹15.35 | +0.23 | +1.5% | ₹15.01 | ₹15.50 | ₹14.60 | 11,876 | |
| ₹15.12 | -0.17 | -1.1% | ₹15.10 | ₹15.84 | ₹14.90 | 9,693 | |
| ₹15.29 | -0.60 | -3.8% | ₹15.10 | ₹15.89 | ₹15.10 | 3,259 | |
| ₹15.89 | -0.06 | -0.4% | ₹15.95 | ₹15.95 | ₹15.41 | 2,862 | |
| ₹15.95 | +0.47 | +3.0% | ₹15.49 | ₹15.99 | ₹15.25 | 6,986 |
Splits
1 split · NSE:ORTINGLOBE · every price before a split is adjusted for it
| Day | Ratio | What |
|---|---|---|
| 12-for-25 | Consolidation |
- Ticker
- NSE:ORTINGLOBE
- Asset type
- Stock
- Sector
- Health care
- Industry
- Pharmaceuticals
- Exchange
- NSE
- Currency
- INR
Latest news
Ortin Global Ltd on 6ix
- Sector
- Health care
- Industry
- Pharmaceuticals
- News releases
- 1 in all · newest Feb 16, 2023 · oldest 2023
Where Ortin Global Ltd is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NSE:ORTINGLOBE · Home listing · This page | NSE | India | INR |
| BSE:ORTINGLOBE | BSE | India | INR |
Valuation
EV/sales 131× against a median of 0.8×: the highest of 11 Pharmaceuticals companies shown. Statements: 4 quarters to Jun 30, 2026 · price Nov 20, 2026
- Enterprise value
- ₹100.6M INR
- P/E
- Loss
- EV/sales
- 131×
- EV/EBITDA
- Negative EBITDA
- Price/book
- 8.1×
- Gross margin
- −139.6%
- Operating margin
- Revenue too small
- Net margin
- Revenue too small
- Debt to equity
- 0.0×
- Beta
- No index for this market yet
Pharmaceuticals: the 10 companies nearest in size, of 492 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| Ortin Global Ltd · NSE:ORTINGLOBE | US$1.09M | US$1.09M | n/a | 131× | n/a | 8.1× | n/a | 0.0× | n/a |
| Vivimed Labs Limited · NSE:VIVIMEDLAB | US$4.49M | US$46.53M | n/a | 6.2× | n/a | n/a | −252.1% | n/a | n/a |
| Acrux Limited · ASX:ACR | US$4.05M | US$4.59M | n/a | 1.5× | n/a | 4.2× | −13.0% | 1.7× | n/a |
| Scilex Holding Company · NASDAQ:SCLX | US$3.98M | US$98.96M | n/a | 3.1× | n/a | n/a | n/a | n/a | 1.46 |
| Scienture Holdings, Inc. · NASDAQ:SCNX | US$3.74M | US$8.36M | n/a | 5.6× | n/a | 0.1× | n/a | 0.2× | 1.74 |
| Sanai Health Industry Group Company Limited · HKEX:1889 | US$2.42M | −US$44.61M | n/a | −3.5× | n/a | 0.1× | −25.7% | 0.0× | n/a |
| Lasa Supergenerics Ltd. · NSE:LASA | US$2.17M | US$2.17M | n/a | 3.2× | n/a | 0.4× | −260.4% | 0.0× | n/a |
| Sunshine Biopharma Inc. · NASDAQ:SBFM | US$1.84M | −US$12.15M | n/a | −0.3× | n/a | 0.1× | −17.4% | 0.0× | 0.95 |
| Rafarma Pharmaceuticals, Inc. (wy) · OTC:RAFA | US$877,670 | US$839,670 | 2.5× | 0.1× | n/a | 0.1× | 3.8% | 0.0× | 0.68 |
| Evofem Biosciences, Inc. · OTC:EVFM | US$834,940 | US$517,940 | n/a | 0.0× | n/a | n/a | −71.7% | n/a | -0.14 |
| China SXT Pharmaceuticals, Inc. · NASDAQ:SXTC | US$273,956 | −US$26.78M | n/a | −23.5× | n/a | 0.0× | −545.2% | 0.0× | 2.04 |
| Median of the others | US$2.29M | US$1.50M | 2.5× | 0.8× | 0.1× | −48.7% | 0.0× | 1.21 |
Team and board
Officers
| Officer | Role |
|---|---|
| Murali Krishna Murthy Sanka | Managing Director |
Board
| Director | Role |
|---|---|
| Gopal Reddy Bheemreddy | Non-Executive Independent Director |
| Murali Krishna Rayaprolu | Non-Executive Independent Director |
| Pottur Sujatha | Non-Executive Independent Director |
| Ramesh Joshi | Whole Time Director |
Financials
Annual, in INR
Income statement
| Line | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.00M | 3.42M | 21.1M | 60.2M | 82.3M | 81.7M | 1.97B | 1.68B | 797.1M | 618.9M |
| Cost of revenue | 2.52M | 2.15M | 37.2M | 33.9M | 46.5M | 41.5M | 1.56B | 1.36B | 579.4M | 367.4M |
| Gross profit | -1.52M | 1.28M | -16.0M | 26.3M | 35.8M | 40.2M | 416.1M | 319.9M | 217.7M | 251.5M |
| Selling, general and administrative | 2.08M | 1.12M | 6.14M | 1.77M | 1.41M | 11.2M | 54.5M | |||
| Operating income | -10.4M | -8.95M | -44.7M | 2.71M | 2.45M | 9.60M | 358.2M | 276.6M | 183.5M | 217.3M |
| Depreciation and amortization | 5.00K | 117.0K | 2.28M | 2.50M | 2.94M | 2.85M | 19.6M | 17.5M | 16.9M | 17.0M |
| EBITDA | -10.4M | -8.84M | -42.4M | 5.21M | 5.39M | 12.5M | 377.7M | 294.1M | 200.4M | 234.3M |
| Interest expense | 22.0K | 23.0K | 4.63M | 3.45M | 7.86M | 8.72M | ||||
| Income before tax | -7.23M | -8.38M | -70.8M | -1.10M | -5.30M | 1.36M | 7.19M | 18.4M | 6.80M | 11.3M |
| Income tax | 170.0K | 89.0K | 9.66M | -169.0K | -1.31M | 8.09M | 12.8M | 5.58M | 11.0K | 6.27M |
| Net income | -7.40M | -8.46M | -80.4M | -936.0K | -3.99M | 9.45M | -5.64M | 12.8M | 6.79M | 5.03M |
| Earnings per share, basic | -0.91 | -1.04 | -9.89 | -0.12 | -0.49 | 1.16 | -0.69 | 1.57 | 0.84 | 0.62 |
Balance sheet
| Line | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 6.06M | 3.74M | 4.59M | 2.56M | 4.92M | 251.3K | 25.0M | 8.91M | 16.9M | 14.3M |
| Short-term investments | 18.8M | 361.0K | 1.03M | 1.51M | ||||||
| Receivables | 2.00M | 2.63M | 18.0M | 34.3M | 32.5M | 39.1M | 371.5M | 378.3M | 218.5M | 152.4M |
| Inventory | 0 | 198.0K | 502.0K | 26.0M | 17.4M | 18.3M | 499.0M | 369.6M | 240.3M | 176.6M |
| Current assets | 38.4M | 33.4M | 63.4M | 65.4M | 57.5M | 61.3M | 924.1M | 820.4M | 523.6M | 382.2M |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | ||||
| Total assets | 46.5M | 37.8M | 66.6M | 212.0M | 207.0M | 212.7M | 1.17B | 1.05B | 736.6M | 615.3M |
| Accounts payable | 384.0K | 423.0K | 782.0K | 15.5M | 7.87M | 13.4M | 600.0M | 476.0M | 165.8M | 46.9M |
| Current liabilities | 24.1M | 15.5M | 20.4M | 69.8M | 76.1M | 78.9M | 838.3M | 721.8M | 416.2M | 305.0M |
| Long-term debt | 10.1M | 2.50M | 18.0M | 29.6M | 17.3M | 14.4M | ||||
| Total debt | 10.1M | 2.50M | 18.1M | 64.5M | 61.4M | 69.4M | 195.7M | 221.5M | 210.3M | 202.5M |
| Total liabilities | 34.1M | 18.0M | 38.4M | 103.3M | 97.5M | 99.1M | 927.0M | 799.9M | 495.9M | 381.3M |
| Shareholders' equity | 12.4M | 19.8M | 28.2M | 108.6M | 109.6M | 113.6M | 238.2M | 250.9M | 240.8M | 234.0M |
| Shares outstanding | 8.14M | 8.13M | 8.13M | 7.80M | 8.14M | 8.15M | 8.20M | 8.13M | 8.13M | 8.13M |
Cash flow
| Line | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | -5.62M | -4.10M | -47.9M | -2.53M | 21.5M | 180.3M | 33.0M | 65.2M | 15.6M | 19.4M |
| Capital spending | -5.62M | -36.0K | 0 | -20.0K | -1.25M | 0 | -31.2M | -31.4M | -12.4M | -11.3M |
| Free cash flow | -5.60M | -4.14M | -47.9M | -2.53M | 20.2M | 180.3M | 1.83M | 33.8M | 3.17M | 8.10M |
| Cash from investing | 390.0K | -36.0K | 120.0M | 82.0K | -1.25M | 695.7K | -30.9M | -32.6M | -8.97M | -12.6M |
| Cash from financing | 7.55M | 3.28M | -34.9M | 9.04M | -4.71M | -98.6M | -13.3M | -28.9M | 667.0K | -8.20M |
| Share buybacks | 0 | -69.2M | ||||||||
| Change in cash | 2.32M | -856.0K | 37.2M | 6.59M | 15.5M | 82.5M | -11.2M | 3.69M | 7.27M | -2.33M |
Filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| Press Release Feb 16 2023 | Feb 16, 2023 | Other filings | NSE India |
Cap table
Built by 6ix from Ortin Global Ltd’s releases
- Common shares
- 8,131,392
- Fully diluted
- 8,131,392
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 8,131,392 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 8,131,392 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Gopal Reddy Bheemreddy | Non-Executive Independent Director · Since at least Nov 6, 2026 |
| Murali Krishna Murthy Sanka | Managing Director · Since at least Nov 6, 2026 |
| Murali Krishna Rayaprolu | Non-Executive Independent Director · Since at least Nov 6, 2026 |
| Pottur Sujatha | Non-Executive Independent Director · Since at least Nov 6, 2026 |
| Ramesh Joshi | Whole Time Director · Since at least Nov 6, 2026 |
Log in to ask 6ix AI your own questions about Ortin Global Ltd.